Cite
HARVARD Citation
Meyer, T. et al. (n.d.). O-021Ramucirumab in advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: outcomes by prior transarterial chemoembolisation from two randomised, double-blind, placebo-controlled phase 3 studies (REACH-2 and REACH). Annals of oncology. p. . [Online].